|
PARS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24578125593189E-12 |
| Normal-vs-Stage2 |
2.09689998698082E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62525548574877E-12 |
| Stage1-vs-Stage2 |
6.976300E-02 |
| Stage1-vs-Stage3 |
6.37079999976642E-07 |
| Stage1-vs-Stage4 |
6.779000E-04 |
| Stage2-vs-Stage3 |
2.338800E-01 |
| Stage2-vs-Stage4 |
4.070600E-01 |
| Stage3-vs-Stage4 |
6.709400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.15799999997635E-06 |
| Normal-vs-Asian |
8.713600E-01 |
| Caucasian-vs-AfricanAmerican |
1.514200E-01 |
| Caucasian-vs-Asian |
2.383400E-01 |
| AfricanAmerican-vs-Asian |
3.686400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.46855877353391E-12 |
| Male-vs-Female |
3.845600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.35819999996989E-06 |
| Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.37169966893691E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.176400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.559400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.310400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.133800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.751010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.599000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.815900E-03 |
| Normal-vs-Grade 2 |
5.93303184359684E-13 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
5.248400E-01 |
| Grade 1-vs-Grade 3 |
1.537440E-01 |
| Grade 1-vs-Grade 4 |
8.322000E-03 |
| Grade 2-vs-Grade 3 |
2.317700E-02 |
| Grade 2-vs-Grade 4 |
7.73020000000013E-05 |
| Grade 3-vs-Grade 4 |
2.284000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62525548574877E-12 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
1.676440E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62492241884138E-12 |
| Normal-vs-N1 |
2.2884999999917E-05 |
| N0-vs-N1 |
9.092800E-01 |
|
|
